Swoop acquires Nimble

Swoop announced its acquisition of Nimble, expanding its platform to include real-time pharmacy connectivity and prescription fulfilment. The deal makes prescription management and adherence data accessible to pharma marketers, agencies, and publishers seeking to connect digital media engagement with measurable patient outcomes.

Nimble operates across all 50 US states, supporting 16 million patients through independent pharmacies. By digitising prescription fills, refills, payment and communications, Nimble has sought to simplify pharmacy workflows and enhances patient support.

For the pharma media industry, this integration is significant: Swoop’s audience intelligence and omnichannel activation capabilities now extend into the pharmacy ‘last mile’, connecting behavioural signals from media campaigns directly to real-world prescription and adherence activity. This looks to create new opportunities to track, optimise, and measure the impact of paid and earned media in driving therapy adoption and persistent patient engagement.

“Nimble accelerates our ability to connect the signals that drive patient and physician behaviour directly to real-world action,” said Ron Elwell, Swoop CEO and Co-Founder. “By bringing prescription fulfilment into Swoop, we are extending our platform beyond engagement to impact – helping life sciences companies improve patient outcomes.”

From a media planning perspective, Swoop’s expanded solution set looks to give marketers and agency leads the ability to target, activate and analyse campaigns with the support of real-time data from pharmacy interactions. Ultimately seeking to offer precise audience segmentation, retargeting, and measurement strategies that incorporate both digital engagement and actual therapy initiation or adherence, provided all privacy and compliance standards are upheld.

“Independent pharmacies are where patient care gets real – they’re the last mile between a prescription and a patient who actually stays on therapy,” said Talha Sattar, Nimble CEO. “Joining Swoop gives Nimble pharmacies a meaningful edge in closing that gap, and that’s good for their business and good for the patients who depend on them.”

solli’s Final Thoughts

The integration of pharmacy fulfilment data into media activation highlights how pharma marketing is evolving beyond traditional engagement metrics toward measurable patient outcomes. By combining Swoop’s audience intelligence and omnichannel activation with Nimble’s real-time pharmacy connectivity, the deal looks to close the loop between digital engagement, prescription initiation, and long-term adherence.

For marketers, agencies, and publishers, this signals growing demand for “closed-loop” healthcare marketing strategies that connect media performance directly to real-world patient behaviour. It also reinforces the increasing value of privacy-safe, consented data partnerships as omnichannel campaigns become more sophisticated and outcome-focused.

Ultimately, the acquisition reflects a wider industry shift which solli has written about a number of times: healthcare marketing is increasingly being measured not just by awareness or clicks, but by its ability to influence tangible patient action and therapy persistence.